UBS AM’s Rentokil RTO Stock Holding History

UBS AM’s Portfolio RTO Stock Details RTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$317K	Hold	11,088	–	–	﹤0.01%	2631
2026 Q1	$349K	Buy	11,088 +9,759	+734%	+$307K	﹤0.01%	2630
2025 Q4	$39.2K	Buy	+1,329	New	+$36.9K	﹤0.01%	2654

Other funds holding RTO

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

GCM

Gates Capital Management New York $4.16B AUM 21% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Summitry LLC Foster City, California $3.04B AUM 17.05% 1-Year Est. Return

UBS AM's RTO Position: Q2 2026 in Review

UBS AM held its Rentokil (RTO) position steady in Q2 2026 at 11,088 shares worth $317K. The position accounts for ﹤0.01% of the portfolio, ranked #2631.

UBS AM first reported a position in RTO in Q4 2025 and has held it in 3 quarters since. The position peaked at $349K in Q1 2026. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

UBS AM held 11,088 shares of Rentokil worth $317K as of Q2 2026.
UBS AM left its Rentokil share count unchanged in Q2 2026.
Rentokil made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2631 holding.
UBS AM first reported a position in Rentokil in Q4 2025 and has held it in 3 quarters since.
UBS AM's Rentokil position peaked at $349K in Q1 2026.
284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.